ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 1 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2023. The put-call ratio across all filers is - and the average weighting 14.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202 | +27.0% | 206,156 | +80.4% | 0.00% | – |
| Q2 2023 | $159 | -100.0% | 114,300 | -60.1% | 0.00% | -100.0% |
| Q3 2022 | $1,921,000 | -21.6% | 286,700 | -25.6% | 0.00% | 0.0% |
| Q2 2022 | $2,451,000 | +25.1% | 385,300 | -8.7% | 0.00% | +50.0% |
| Q1 2022 | $1,959,000 | -62.3% | 422,200 | +197.5% | 0.00% | -50.0% |
| Q3 2019 | $5,202,000 | -52.9% | 141,900 | -40.3% | 0.00% | -60.0% |
| Q2 2019 | $11,049,000 | +40.7% | 237,500 | +21.4% | 0.01% | +42.9% |
| Q1 2019 | $7,853,000 | +854.2% | 195,595 | +992.7% | 0.01% | +600.0% |
| Q4 2018 | $823,000 | +13.2% | 17,900 | +23.4% | 0.00% | 0.0% |
| Q3 2017 | $727,000 | -83.5% | 14,500 | -95.5% | 0.00% | -87.5% |
| Q3 2016 | $4,415,000 | +142.6% | 318,800 | +196.3% | 0.01% | +166.7% |
| Q1 2016 | $1,820,000 | -77.4% | 107,600 | -70.2% | 0.00% | -83.3% |
| Q4 2015 | $8,040,000 | – | 361,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |